TITLE:
Study of Daclizumab in Patients With Chronic, Persistent Asthma

CONDITION:
Asthma

INTERVENTION:
Daclizumab

SUMMARY:

      The purpose of the study is to evaluate an investigational medication to treat chronic
      persistent asthma. The research is being conducted at up to 22 clinical research sites in
      the US and is open to both men and women ages 18 to 70 years old. Participants in the study
      will have a number of visits to a research site over a 10-month period. All study-related
      care and medication is provided to qualified participants at no cost: this includes all
      visits, examinations and laboratory work.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 70 Years
Criteria:

        Inclusion Criteria:

          -  History of asthma for 6 or more months

          -  History of chronic persistent asthma requiring daily high dose inhaled corticosteroid
             for 3 or more months prior to enrollment

        Exclusion Criteria:

          -  Patients with 10 or more pack years of smoking history or smoking within 12 months of
             study enrollment

          -  No significant disease other than asthma
      
